Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01220583
Other study ID # RTOG-1008
Secondary ID CDR0000686072NCI
Status Active, not recruiting
Phase Phase 2
First received
Last updated
Start date January 2011
Est. completion date October 2028

Study information

Verified date January 2024
Source Radiation Therapy Oncology Group
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether radiation therapy is more effective when given together with chemotherapy or alone after surgery in treating salivary gland tumors. PURPOSE: This randomized phase II/III trial is studying radiation therapy with or without chemotherapy to see how well it works in treating patients with high-risk malignant salivary gland tumors that have been removed by surgery.


Description:

OBJECTIVES: Primary Phase II - Determine the feasibility of conducting a cooperative group prospective clinical trial in patients with resected malignant salivary gland tumors. - Acquire preliminary efficacy data comparing postoperative radiotherapy alone to concurrent chemotherapy and radiation using weekly cisplatin. Phase III * Compare overall survival rates among patients receiving cisplatin and radiation to those receiving radiation alone. Secondary Phase II/III - Compare the acute toxicities of these 2 adjuvant treatments. - Compare late treatment-related adverse events in patients receiving postoperative radiation to those receiving concurrent chemoradiation. - Compare progression-free survival rates among patients receiving cisplatin and radiation to those receiving radiation alone in both the cohort of patients with pathologically high-risk disease (high-grade adenocarcinoma, high-grade mucoepidermoid carcinoma, salivary duct carcinoma), and the patient cohort with pathologically intermediate-risk disease (all other eligible diagnoses). - Investigate quality of life and patient-reported outcomes in patients enrolled in the study. - Identify the histopathology and tumor marker expression from patients enrolled on this trial and assemble a tissue bank for future correlative studies. - Establish a NRG Oncology baseline database for salivary gland malignancies to serve as a resource for future exploration of innovative and/or targeted approaches for this disease. OUTLINE: This is a multicenter study. Patients are stratified according to histology (high-grade mucoepidermoid carcinoma vs salivary duct carcinoma vs high-grade adenocarcinoma) and nodal status (N0 vs N1-3). Patients are randomized to 1 of 2 treatment arms. - Arm I: Patients undergo 3-dimensional conformal radiotherapy (3D-CRT) or intensity-modulated radiotherapy (IMRT) 5 days a week for 6-6.5 weeks. Patients also receive cisplatin IV over 60 minutes on days 1, 8, 15, 22, 29, 36, and 43 during radiotherapy. - Arm II: Patients undergo 3D-CRT or IMRT as in Arm I. Tissue and blood samples may be collected for translational research studies. Patients may complete quality-of-life assessments periodically. After completion of study treatment, patients are followed up at 3, 6, 9, 12, and 24 months, every 6 months for 2 years, and then annually thereafter.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 252
Est. completion date October 2028
Est. primary completion date October 31, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility DISEASE CHARACTERISTICS: - Pathologically proven diagnosis of a malignant major salivary gland tumor or malignant minor salivary gland tumor of the head and neck of the following histologic subtypes: - Intermediate-grade adenocarcinoma or intermediate-grade mucoepidermoid carcinoma - High-grade acinic cell carcinoma or high-grade (>30% solid component) adenoid cystic carcinoma - Surgical resection with curative intent within 8 weeks prior to registration - All patients must have a Medical Oncology evaluation within 4 weeks prior to registration - Pathologic stage T3-4 or N1-3 or T1-2, N0 with a close (= 1mm) or microscopically positive surgical margin; patients must be free of distant metastases based upon the following minimum diagnostic workup: - History/physical examination within 8 weeks prior to registration - Radiologic confirmation of the absence of hematogenous metastasis within 12 weeks prior to registration; at a minimum, contrast CT imaging of the chest is required (PET/CT is acceptable) - No patients with residual macroscopic disease after surgery - No prior systemic chemotherapy or radiation therapy for salivary gland malignancy PATIENT CHARACTERISTICS: - Zubrod performance status 0-1 - Absolute neutrophil count (ANC) = 1,800 cells/mm^3 - Platelets = 100,000 cells/mm^3 - Hemoglobin = 8.0 g/dL (the use of transfusion or other intervention to achieve hemoglobin = 8.0 g/dL is acceptable) - Serum creatinine < 2.0 mg/dL - Total bilirubin < 2 x the institutional upper limit of normal (ULN) - Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) < 3 x the institutional ULN - Negative serum pregnancy test within 2 weeks prior to registration for women of childbearing potential - Women of childbearing potential and male participants who are sexually active must practice adequate contraception during treatment and for 6 weeks following treatment - Not pregnant or nursing - Patients must be deemed able to comply with the treatment plan and follow-up schedule - Patients must provide study specific informed consent prior to study entry, including consent for mandatory tissue submission for central review - No prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years (for example, carcinoma in situ of the breast, oral cavity, or cervix are all permissible) - No severe, active co-morbidity, defined as follows: - Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months - Transmural myocardial infarction within the last 6 months - Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration - Chronic Obstructive Pulmonary Disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration - Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects (coagulation parameters are not required for entry into this protocol) - Acquired immune deficiency syndrome (AIDS) based upon current Centers for Disease Control (CDC) definition (HIV testing is not required for entry into this protocol) - Protocol-specific requirements may also exclude immunocompromised patients - Pre-existing = grade 2 neuropathy - No significant pre-existing hearing loss, as defined by the patient or treating physician PRIOR CONCURRENT THERAPY: - See Disease Characteristics - No prior systemic chemotherapy or radiation therapy for salivary gland malignancy (prior chemotherapy for a different cancer is allowable) - No prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields - No prior organ transplant - No concurrent hematopoietic growth factors (e.g., G-CSF or pegfilgrastim) during radiotherapy - No concurrent erythropoiesis-stimulating agents

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
cisplatin
Given IV
Radiation:
3-dimensional conformal radiation therapy
Undergo radiotherapy
intensity-modulated radiation therapy
Undergo radiotherapy

Locations

Country Name City State
Canada Cross Cancer Institute Edmonton Alberta
Canada London Regional Cancer Program London Ontario
Canada CHUM - Centre Hospitalier de l'Universite de Montreal Montreal Quebec
Canada CHUM - Hopital Notre-Dame Montreal Quebec
Canada McGill University Department of Oncology Montreal Quebec
Canada The Research Institute of the McGill University Health Centre (MUHC) Montreal Quebec
Canada Health Sciences North Sudbury Ontario
Canada University Health Network-Princess Margaret Hospital Toronto Ontario
Saudi Arabia King Faisal Specialist Hospital and Research Centre Riyadh
United States Bixby Medical Center Adrian Michigan
United States Summa Health System - Akron Campus Akron Ohio
United States University of New Mexico Cancer Center Albuquerque New Mexico
United States Lehigh Valley Hospital-Cedar Crest Allentown Pennsylvania
United States American Fork Hospital / Huntsman Intermountain Cancer Center American Fork Utah
United States McFarland Clinic PC - Ames Ames Iowa
United States Saint Joseph Mercy Hospital Ann Arbor Michigan
United States University of Michigan Comprehensive Cancer Center Ann Arbor Michigan
United States Emory Proton Therapy Center Atlanta Georgia
United States Emory University Hospital Midtown Atlanta Georgia
United States Emory University Hospital/Winship Cancer Institute Atlanta Georgia
United States Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn California
United States Rocky Mountain Cancer Centers-Aurora Aurora Colorado
United States University of Colorado Hospital Aurora Colorado
United States AIS Cancer Center at San Joaquin Community Hospital Bakersfield California
United States Greater Baltimore Medical Center Baltimore Maryland
United States Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland
United States Summa Health System - Barberton Campus Barberton Ohio
United States Memorial Sloan Kettering Basking Ridge Basking Ridge New Jersey
United States Mary Bird Perkins Cancer Center Baton Rouge Louisiana
United States Northwell Health Imbert Cancer Center Bay Shore New York
United States Billings Clinic Cancer Center Billings Montana
United States The Kirklin Clinic at Acton Road Birmingham Alabama
United States University of Alabama at Birmingham Cancer Center Birmingham Alabama
United States Prisma Health Cancer Institute - Spartanburg Boiling Springs South Carolina
United States Saint Alphonsus Cancer Care Center-Boise Boise Idaho
United States Boston Medical Center Boston Massachusetts
United States Boulder Community Hospital Boulder Colorado
United States Bozeman Deaconess Hospital Bozeman Montana
United States Maimonides Medical Center Brooklyn New York
United States Henry Ford Cancer Institute-Downriver Brownstown Michigan
United States Bryn Mawr Hospital Bryn Mawr Pennsylvania
United States Mills-Peninsula Medical Center Burlingame California
United States Aurora Cancer Care-Southern Lakes VLCC Burlington Wisconsin
United States Sutter Cancer Centers Radiation Oncology Services-Cameron Park Cameron Park California
United States IU Health North Hospital Carmel Indiana
United States Mercy San Juan Medical Center Carmichael California
United States Sandra L Maxwell Cancer Center Cedar City Utah
United States UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina
United States Medical University of South Carolina Charleston South Carolina
United States John H Stroger Jr Hospital of Cook County Chicago Illinois
United States Northwestern University Chicago Illinois
United States University of Cincinnati Cancer Center-UC Medical Center Cincinnati Ohio
United States Clackamas Radiation Oncology Center Clackamas Oregon
United States Case Western Reserve University Cleveland Ohio
United States Cleveland Clinic Foundation Cleveland Ohio
United States Henry Ford Macomb Hospital-Clinton Township Clinton Township Michigan
United States Penrose-Saint Francis Healthcare Colorado Springs Colorado
United States University of Missouri - Ellis Fischel Columbia Missouri
United States Ohio State University Comprehensive Cancer Center Columbus Ohio
United States Memorial Sloan Kettering Commack Commack New York
United States MD Anderson in The Woodlands Conroe Texas
United States UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables Florida
United States Siteman Cancer Center at West County Hospital Creve Coeur Missouri
United States UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas
United States Geisinger Medical Center Danville Pennsylvania
United States UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach Florida
United States Porter Adventist Hospital Denver Colorado
United States Iowa Methodist Medical Center Des Moines Iowa
United States Mercy Medical Center - Des Moines Des Moines Iowa
United States Ascension Saint John Hospital Detroit Michigan
United States Henry Ford Hospital Detroit Michigan
United States Wayne State University/Karmanos Cancer Institute Detroit Michigan
United States City of Hope Comprehensive Cancer Center Duarte California
United States Duke University Medical Center Durham North Carolina
United States Mercy Cancer Center-Elyria Elyria Ohio
United States Swedish Medical Center Englewood Colorado
United States Inova Schar Cancer Institute Fairfax Virginia
United States Inova Fairfax Hospital Falls Church Virginia
United States Weisberg Cancer Treatment Center Farmington Hills Michigan
United States Saint Francis Hospital Federal Way Washington
United States Genesys Hurley Cancer Institute Flint Michigan
United States Aurora Health Center-Fond du Lac Fond Du Lac Wisconsin
United States University of Florida Health Science Center - Gainesville Gainesville Florida
United States Aurora Health Care Germantown Health Center Germantown Wisconsin
United States Arizona Breast Cancer Specialists-Gilbert Gilbert Arizona
United States Goshen Center for Cancer Care Goshen Indiana
United States Aurora Cancer Care-Grafton Grafton Wisconsin
United States Aurora BayCare Medical Center Green Bay Wisconsin
United States Green Bay Oncology at Saint Vincent Hospital Green Bay Wisconsin
United States Saint Vincent Hospital Cancer Center at Saint Mary's Green Bay Wisconsin
United States Saint Vincent Hospital Cancer Center Green Bay Green Bay Wisconsin
United States UPMC Cancer Centers - Arnold Palmer Pavilion Greensburg Pennsylvania
United States Prisma Health Cancer Institute - Eastside Greenville South Carolina
United States Prisma Health Cancer Institute - Faris Greenville South Carolina
United States Prisma Health Cancer Institute - Greer Greer South Carolina
United States Sentara Cancer Institute at Sentara CarePlex Hospital Hampton Virginia
United States UPMC Pinnacle Cancer Center/Community Osteopathic Campus Harrisburg Pennsylvania
United States Memorial Sloan Kettering Westchester Harrison New York
United States Comprehensive Cancer Centers of Nevada - Henderson Henderson Nevada
United States Penn State Milton S Hershey Medical Center Hershey Pennsylvania
United States M D Anderson Cancer Center Houston Texas
United States MD Anderson West Houston Houston Texas
United States Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana
United States Sidney and Lois Eskenazi Hospital Indianapolis Indiana
United States University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa
United States University of Mississippi Medical Center Jackson Mississippi
United States Baptist MD Anderson Cancer Center Jacksonville Florida
United States University of Florida Health Science Center - Jacksonville Jacksonville Florida
United States Freeman Health System Joplin Missouri
United States West Michigan Cancer Center Kalamazoo Michigan
United States Kalispell Regional Medical Center Kalispell Montana
United States University of Kansas Cancer Center Kansas City Kansas
United States Aurora Cancer Care-Kenosha South Kenosha Wisconsin
United States University of Tennessee - Knoxville Knoxville Tennessee
United States UC San Diego Moores Cancer Center La Jolla California
United States Northwell Health/Center for Advanced Medicine Lake Success New York
United States Comprehensive Cancer Centers of Nevada Las Vegas Nevada
United States Comprehensive Cancer Centers of Nevada - Central Valley Las Vegas Nevada
United States Comprehensive Cancer Centers of Nevada - Northwest Las Vegas Nevada
United States Comprehensive Cancer Centers of Nevada-Summerlin Las Vegas Nevada
United States Radiation Oncology Centers of Nevada Central Las Vegas Nevada
United States MD Anderson League City League City Texas
United States Dartmouth Hitchcock Medical Center Lebanon New Hampshire
United States Geisinger Medical Oncology-Lewisburg Lewisburg Pennsylvania
United States Lewistown Hospital Lewistown Pennsylvania
United States University of Kentucky/Markey Cancer Center Lexington Kentucky
United States Rocky Mountain Cancer Centers-Littleton Littleton Colorado
United States Saint Mary Mercy Hospital Livonia Michigan
United States Logan Regional Hospital Logan Utah
United States Longmont United Hospital Longmont Colorado
United States Los Angeles County-USC Medical Center Los Angeles California
United States USC / Norris Comprehensive Cancer Center Los Angeles California
United States The James Graham Brown Cancer Center at University of Louisville Louisville Kentucky
United States McKee Medical Center Loveland Colorado
United States University of Wisconsin Hospital and Clinics Madison Wisconsin
United States Aurora Bay Area Medical Group-Marinette Marinette Wisconsin
United States Bay Area Medical Center Marinette Wisconsin
United States Fremont - Rideout Cancer Center Marysville California
United States Loyola University Medical Center Maywood Illinois
United States Summa Health Medina Medical Center Medina Ohio
United States UH Seidman Cancer Center at Lake Health Mentor Campus Mentor Ohio
United States Miami Cancer Institute Miami Florida
United States University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida
United States UH Seidman Cancer Center at Southwest General Hospital Middleburg Heights Ohio
United States Memorial Sloan Kettering Monmouth Middletown New Jersey
United States Aurora Cancer Care-Milwaukee Milwaukee Wisconsin
United States Aurora Saint Luke's Medical Center Milwaukee Wisconsin
United States Medical College of Wisconsin Milwaukee Wisconsin
United States Memorial Medical Center Modesto California
United States Memorial Sloan Kettering Bergen Montvale New Jersey
United States UPMC-Coraopolis/Heritage Valley Radiation Oncology Moon Pennsylvania
United States West Virginia University Healthcare Morgantown West Virginia
United States Virtua Memorial Mount Holly New Jersey
United States Intermountain Medical Center Murray Utah
United States Vanderbilt University/Ingram Cancer Center Nashville Tennessee
United States UPMC Jameson New Castle Pennsylvania
United States Long Island Jewish Medical Center New Hyde Park New York
United States Ochsner Medical Center Jefferson New Orleans Louisiana
United States Touro Infirmary New Orleans Louisiana
United States University Medical Center New Orleans New Orleans Louisiana
United States Laura and Isaac Perlmutter Cancer Center at NYU Langone New York New York
United States Lenox Hill Hospital New York New York
United States Memorial Sloan Kettering Cancer Center New York New York
United States Mount Sinai Chelsea New York New York
United States Mount Sinai Hospital New York New York
United States Mount Sinai Union Square New York New York
United States Christiana Care Health System-Christiana Hospital Newark Delaware
United States Helen F Graham Cancer Center Newark Delaware
United States Rutgers New Jersey Medical School Newark New Jersey
United States Hoag Memorial Hospital Newport Beach California
United States Sentara Norfolk General Hospital Norfolk Virginia
United States William Backus Hospital Norwich Connecticut
United States Mercy Hospital Oklahoma City Oklahoma City Oklahoma
United States University of Oklahoma Health Sciences Center Oklahoma City Oklahoma
United States Alegent Health Bergan Mercy Medical Center Omaha Nebraska
United States Nebraska Methodist Hospital Omaha Nebraska
United States Saint Joseph Hospital - Orange Orange California
United States Orlando Health Cancer Institute Orlando Florida
United States Vince Lombardi Cancer Clinic - Oshkosh Oshkosh Wisconsin
United States Stanford Cancer Institute Palo Alto Palo Alto California
United States Paoli Memorial Hospital Paoli Pennsylvania
United States University Hospitals Parma Medical Center Parma Ohio
United States Arizona Center for Cancer Care-Peoria Peoria Arizona
United States Fox Chase Cancer Center Philadelphia Pennsylvania
United States Temple University Hospital Philadelphia Pennsylvania
United States Thomas Jefferson University Hospital Philadelphia Pennsylvania
United States Arizona Breast Cancer Specialists-Phoenix Phoenix Arizona
United States Arizona Oncology-Deer Valley Center Phoenix Arizona
United States Cancer Center at Saint Joseph's Phoenix Arizona
United States UPMC Jefferson Regional Radiation Oncology Pittsburgh Pennsylvania
United States UPMC-Passavant Hospital Pittsburgh Pennsylvania
United States UPMC-Saint Clair Hospital Cancer Center Pittsburgh Pennsylvania
United States UPMC-Saint Margaret Pittsburgh Pennsylvania
United States UPMC-Shadyside Hospital Pittsburgh Pennsylvania
United States Saint Joseph Mercy Oakland Pontiac Michigan
United States Lake Huron Medical Center Port Huron Michigan
United States Oregon Health and Science University Portland Oregon
United States Providence Portland Medical Center Portland Oregon
United States Providence Saint Vincent Medical Center Portland Oregon
United States Kootenai Clinic Cancer Services - Post Falls Post Falls Idaho
United States Utah Valley Regional Medical Center Provo Utah
United States Aurora Cancer Care-Racine Racine Wisconsin
United States Rapid City Regional Hospital Rapid City South Dakota
United States Beebe Health Campus Rehoboth Beach Delaware
United States Highland Hospital Rochester New York
United States Mayo Clinic in Rochester Rochester Minnesota
United States University of Rochester Rochester New York
United States Delbert Day Cancer Institute at PCRMC Rolla Missouri
United States Sutter Cancer Centers Radiation Oncology Services-Roseville Roseville California
United States Sutter Medical Center Sacramento Sacramento California
United States University of California Davis Comprehensive Cancer Center Sacramento California
United States Ascension Saint Mary's Hospital Saginaw Michigan
United States Dixie Medical Center Regional Cancer Center Saint George Utah
United States Norris Cotton Cancer Center-North Saint Johnsbury Vermont
United States Siteman Cancer Center-South County Saint Louis Missouri
United States SSM Health Saint Louis University Hospital Saint Louis Missouri
United States Washington University School of Medicine Saint Louis Missouri
United States Siteman Cancer Center at Saint Peters Hospital Saint Peters Missouri
United States UH Seidman Cancer Center at Salem Regional Medical Center Salem Ohio
United States Utah Cancer Specialists-Salt Lake City Salt Lake City Utah
United States UCSF Medical Center-Mission Bay San Francisco California
United States UCSF Medical Center-Mount Zion San Francisco California
United States UH Seidman Cancer Center at Firelands Regional Medical Center Sandusky Ohio
United States Memorial Health University Medical Center Savannah Georgia
United States Arizona Breast Cancer Specialists Scottsdale Arizona
United States Arizona Breast Cancer Specialists-Scottsdale Scottsdale Arizona
United States Arizona Oncology Services Foundation Scottsdale Arizona
United States Seattle Cancer Care Alliance at Northwest Hospital Seattle Washington
United States University of Washington Medical Center - Montlake Seattle Washington
United States Prisma Health Cancer Institute - Seneca Seneca South Carolina
United States Vince Lombardi Cancer Clinic-Sheboygan Sheboygan Wisconsin
United States Siouxland Regional Cancer Center Sioux City Iowa
United States Memorial Sloan Kettering Sleepy Hollow Sleepy Hollow New York
United States Memorial Hospital of South Bend South Bend Indiana
United States Sparta Cancer Treatment Center Sparta New Jersey
United States Mercy Hospital Springfield Springfield Missouri
United States Saint John's Hospital Springfield Illinois
United States Saint Vincent Hospital Cancer Center at Sturgeon Bay Sturgeon Bay Wisconsin
United States MD Anderson in Sugar Land Sugar Land Texas
United States Aurora Medical Center in Summit Summit Wisconsin
United States Arizona Center for Cancer Care-Surprise Surprise Arizona
United States ProMedica Flower Hospital Sylvania Ohio
United States State University of New York Upstate Medical University Syracuse New York
United States Moffitt Cancer Center Tampa Florida
United States North Suburban Medical Center Thornton Colorado
United States Rocky Mountain Cancer Centers-Thornton Thornton Colorado
United States Mercy Health - Saint Anne Hospital Toledo Ohio
United States University of Toledo Toledo Ohio
United States Banner University Medical Center - Tucson Tucson Arizona
United States University of Arizona Cancer Center-North Campus Tucson Arizona
United States University of Arizona Cancer Center-Orange Grove Campus Tucson Arizona
United States Vince Lombardi Cancer Clinic-Two Rivers Two Rivers Wisconsin
United States Memorial Sloan Kettering Nassau Uniondale New York
United States Sutter Cancer Centers Radiation Oncology Services-Vacaville Vacaville California
United States Compass Oncology Vancouver Vancouver Washington
United States PeaceHealth Southwest Medical Center Vancouver Washington
United States Sentara Virginia Beach General Hospital Virginia Beach Virginia
United States Virtua Voorhees Voorhees New Jersey
United States Saint John Macomb-Oakland Hospital Warren Michigan
United States Aurora Cancer Care-Milwaukee West Wauwatosa Wisconsin
United States Aurora West Allis Medical Center West Allis Wisconsin
United States Henry Ford West Bloomfield Hospital West Bloomfield Michigan
United States University of Cincinnati Cancer Center-West Chester West Chester Ohio
United States Wheeling Hospital/Schiffler Cancer Center Wheeling West Virginia
United States Geisinger Wyoming Valley/Henry Cancer Center Wilkes-Barre Pennsylvania
United States Aspirus Cancer Care - Wisconsin Rapids Wisconsin Rapids Wisconsin
United States Cancer Treatment Center Wooster Ohio
United States Lankenau Medical Center Wynnewood Pennsylvania

Sponsors (3)

Lead Sponsor Collaborator
Radiation Therapy Oncology Group National Cancer Institute (NCI), NRG Oncology

Countries where clinical trial is conducted

United States,  Canada,  Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Progression-free survival (PFS), defined by the events of local-regional progression or recurrence, distant metastasis, or death from any cause, primarily at 2 years From randomization to 2 years.
Secondary Overall survival (OS) rate at 2 years From randomization to 2 years.
Secondary PFS rate at 5 years From randomization to 5 years.
Secondary OS rate at 5 years From randomization to 5 years.
Secondary Treatment-related toxicity, defined as any grade 3-4 adverse events (CTCAE v. 4) deemed to be definitely, probably, or possibly related to protocol treatment From start of treatment to last follow-up.
Secondary Treatment-related mortality, defined as any death during or within 30 days of discontinuation of protocol treatment From start of treatment to 30 days after the end of treatment.
Secondary Chemotherapy delivery as measured by percentage of protocol prescription given From start of treatment to end of treatment.
Secondary Radiation delivery as measured by elapsed treatment days From start of treatment to end of treatment.
Secondary Determine whether quality of life, fatigue and xerostomia differ as a function of treatment assignment at 3, 12, and 24 months after completing radiotherapy. From randomization to 2 years.
See also
  Status Clinical Trial Phase
Recruiting NCT05808920 - The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck
Completed NCT02526017 - Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers Phase 1
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT03997643 - Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Recruiting NCT04700475 - Effect of Low Level Laser Therapy on Prevention of Radiotherapy Induced Xerostomia in Cancer Patients. N/A
Withdrawn NCT04058145 - AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma Phase 2
Completed NCT02572869 - Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps
Active, not recruiting NCT04474470 - A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer Phase 1/Phase 2
Withdrawn NCT05073809 - Photoacoustic Imaging of Head and Neck Tumours
Active, not recruiting NCT04383210 - Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Phase 2
Active, not recruiting NCT03651570 - Randomized Controlled Trial of a E-intervention to Help Patients Newly Diagnosed With Cancer Cope Better: Pilot Study N/A
Recruiting NCT04930432 - Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors Phase 1/Phase 2
Recruiting NCT06016699 - Immunological Function After Radiation With Either Proton or Photon Therapy
Terminated NCT03843554 - Commensal Oral Microbiota in Head and Neck Cancer N/A
Recruiting NCT05915572 - Mulligan Technique on Shoulder Dysfunction N/A
Completed NCT05897983 - Tens and Rocabado Exercises on TMJ Dysfunction N/A
Not yet recruiting NCT06289049 - Heavy Strength Training in Head and Neck Cancer Survivors Phase 2
Withdrawn NCT05263648 - Virtual Reality Software to Reduce Stress in Cancer Patients N/A
Withdrawn NCT03238638 - A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy Phase 2